Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Capitalization 438M 485M 37.01B P/E ratio 2024 *
14.7x
P/E ratio 2025 * 10.9x
Enterprise value 582M 644M 49.14B EV / Sales 2024 *
0.87x
EV / Sales 2025 * 0.77x
Free-Float
42.94%
Yield 2024 *
1.67%
Yield 2025 * 1.94%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.95%
1 week+6.09%
Current month+0.14%
1 month+2.35%
3 months-7.93%
6 months+8.91%
Current year+78.72%
More quotes
1 week
32.80
Extreme 32.8
35.05
1 month
32.80
Extreme 32.8
35.45
Current year
17.02
Extreme 17.02
40.25
1 year
15.48
Extreme 15.48
40.25
3 years
15.28
Extreme 15.28
45.65
5 years
15.28
Extreme 15.28
54.00
10 years
15.28
Extreme 15.28
90.64
More quotes
Director TitleAgeSince
Chief Executive Officer 55 31/01/18
Director of Finance/CFO - 31/03/19
Chief Tech/Sci/R&D Officer - -
Manager TitleAgeSince
Director/Board Member 63 23/05/13
Director/Board Member 65 22/05/14
Director/Board Member 68 22/05/14
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+2.95%+6.09%+70.42%-3.46%486M
+1.20%-5.09%-7.65% - 11.26B
-1.35%-9.09%-45.45%-53.31%1.7B
-4.43%-10.04%-42.94%-12.62%1.61B
-1.48%-1.64%-34.71%-40.67%1.19B
+1.23%+7.98%+9.66%+39.68%614M
+1.94%+7.12%-14.82%-72.08%370M
+1.87%-0.52%+49.80%-41.05%310M
-4.26%-.--%-.--%+62.50%189M
-0.19%+1.36%-22.55%-35.95%180M
Average -0.25%-0.10%-3.83%-17.44% 1.79B
Weighted average by Cap. +0.28%-1.82%-12.73%-25.69%
See all sector performances

Financials

2024 *2025 *
Net sales 858M 950M 72.44B 924M 1.02B 78.01B
Net income 29.8M 33M 2.52B 40.27M 44.59M 3.4B
Net Debt 305M 338M 25.74B 271M 300M 22.89B
More financial data * Estimated data
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (55.4%); - MRI products (32.7%); - other (11.9%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2023 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Europe accounts for 39.7% of net sales.
Employees
2,920
Calendar
More about the company
Date Price Change Volume
13/09/24 34.85 +2.95% 6,844
12/09/24 33.85 +1.65% 6,214
11/09/24 33.30 -0.45% 4,137
10/09/24 33.45 +0.45% 4,717
09/09/24 33.30 +1.37% 3,009

Real-time Euronext Paris, September 13, 2024 at 04:35 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
34.85EUR
Average target price
40.71EUR
Spread / Average Target
+16.83%
Consensus

Quarterly revenue - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW